| FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
| RERE |
Q9P2R6
|
arginine-glutamic acid dipeptide repeats
|
|
1.00 |
0.526 |
0.846 |
| BCL6 |
P41182
|
BCL6 transcription repressor
|
|
0.96 |
0.444 |
0.808 |
| PRDM1 |
O75626
|
PR/SET domain 1
|
|
0.96 |
0.538 |
0.731 |
| BMI1 |
P35226
|
BMI1 proto-oncogene, polycomb ring finger
|
|
0.94 |
0.448 |
0.808 |
| CD19 |
P15391
|
CD19 molecule
|
|
0.90 |
0.430 |
0.885 |
| CD28 |
P10747
|
CD28 molecule
|
|
0.36 |
0.436 |
0.885 |
| TNFRSF8 |
P28908
|
TNF receptor superfamily member 8
|
|
0.86 |
0.444 |
0.808 |
| CD40 |
P25942
|
CD40 molecule
|
|
0.85 |
0.396 |
0.846 |
| CD44 |
P16070
|
CD44 molecule (Indian blood group)
|
|
2.4E-07 |
0.363 |
0.962 |
| CD70 |
P32970
|
CD70 molecule
|
|
1.0E-02 |
0.542 |
0.692 |
| CDKN1A |
P38936
|
cyclin dependent kinase inhibitor 1A
|
|
1.9E-03 |
0.403 |
0.769 |
| CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
| CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
| CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
| CHGB |
P05060
|
chromogranin B
|
|
2.4E-07 |
0.599 |
0.654 |
| CR2 |
P20023
|
complement C3d receptor 2
|
|
4.7E-19 |
0.556 |
0.654 |
| CXADR |
P78310
|
CXADR Ig-like cell adhesion molecule
|
|
0.37 |
0.454 |
0.885 |
| DDIT3 |
P35638
|
DNA damage inducible transcript 3
|
|
0.59 |
0.467 |
0.846 |
| DNMT3B |
Q9UBC3
|
DNA methyltransferase 3 beta
|
|
0.20 |
0.453 |
0.846 |
| EP300 |
Q09472
|
E1A binding protein p300
|
|
1.00 |
0.459 |
0.846 |
| FOXO1 |
Q12778
|
forkhead box O1
|
|
1.00 |
0.433 |
0.846 |
| GBA |
P04062
|
glucosylceramidase beta
|
|
1.4E-06 |
0.500 |
0.808 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |